Russel T Burge

15PUBLICATIONS
34CO-AUTHORS
Disease surveillancePacific Peoples theory of change models for healthRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 20, 2024
Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data.

Jamie L W Rhoads, William N Malatestinic, Russel Burge

|Nov 27, 2022
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program.

Wayne Gulliver, Melinda J Gooderham, Baojin Zhu

|Jun 06, 2022
Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non-responders: Subgroup analysis of UNCOVER-3 trial.

D Rosmarin, S Smith, D Shrom

|May 26, 2022
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings.

Andrew Blauvelt, Nianwen Shi, Mwangi J Murage

|Mar 22, 2022
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.

Craig L Leonardi, Kyoungah See, Russel Burge

|Nov 23, 2021
A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.

Jake Macey, Helen Kitchen, Natalie V J Aldhouse

Pageof 3

Frequent Collaborators

3 joint publications

Alexander Egeberg

3 joint publications

Andrew Blauvelt

2 joint publications

Melinda J Gooderham

2 joint publications

Mwangi J Murage